A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology

Cited by (1,005)

Items 301–400 of 1,005

  1. Immunometabolic mechanisms of heart failure with preserved ejection fraction
    Gabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, Thomas G. Gillette, Stephane R B Heymans, Elizabeth A. V. Jones, Marinos Kallikourdis, Andrew H. Lichtman, Federica M. Marelli‐Berg, Sanjiv Jayendra Shah et al. · 2022 · Nature Cardiovascular Research
  2. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
    van Woerden, Gijs, van Veldhuisen, Dirk J., Westenbrink, B. Daan, de Boer, Rudolf A., Rienstra, Michiel, Gorter, Thomas M. · 2022 · European Journal of Heart Failure
  3. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential
    Roman Roy, Joshua Wilcox, Andrew J. Webb, Kevin O’Gallagher · 2023 · International Journal of Molecular Sciences
  4. Heart Failure With Preserved Ejection Fraction Expert Panel Report
    Kishan S. Parikh, Kavita Sharma, Mona Fiuzat, Howard K. Surks, Jyothis Thomas George, Narimon Honarpour, Christophe Depré, Patrice M. Desvigne-Nickens, Richard Nkulikiyinka, Gregory D. Lewis et al. · 2018 · JACC Heart Failure
  5. Cardiac changes associated with vascular aging
    Narayana Sarma V. Singam, Christopher Fine, Jerome L. Fleg · 2019 · Clinical Cardiology
  6. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
    Donato Cappetta, Antonella De Angelis, Loreta Pia Ciuffreda, Raffaele Coppini, Anna Cozzolino, Agostino Miccichè, Carmela Dell’Aversana, Domenico D’Amario, Eleonora Cianflone, Cristina Scavone et al. · 2020 · Pharmacological Research
  7. Key inflammatory mechanisms underlying heart failure
    Christian Riehle, Johann K Bauersachs · 2019 · Herz
  8. Macrophages and Cardiovascular Health
    Vanessa Frodermann, Matthias Nahrendorf · 2018 · Physiological Reviews
  9. Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
    Joshua F. Lee, Zachary Barrett‐O’Keefe, Ryan S. Garten, Ashley D. Nelson, John Jake Ryan, Jose N. Nativi, Russell S. Richardson, David Walter Wray · 2015 · Heart
  10. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction
    Walter J. Paulus, Elisa Dal Canto · 2017 · JACC Heart Failure
  11. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
    Mauro Gori, Michele Senni, Deepak K. Gupta, David M. Charytan, Elisabeth Kraigher‐Krainer, Burkert Mathias Pieske, Brian Lee Claggett, Amil M. Shah, Ângela Barreto Santiago Santos, Michael R. Zile et al. · 2014 · European Heart Journal
  12. Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and Beyond
    Carsten Tschöpe, Behrouz Kherad, Oliver Klein, Axel Lipp, Florian Blaschke, David D. Gutterman, Daniel Burkhoff, Nazha Hamdani, Frank Spillmann, Sophie Van Linthout · 2018 · European Journal of Heart Failure
  13. Characteristics, Treatments and 1-Year Prognosis of Hospitalized and Ambulatory Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the European Society of Cardiology Heart Failure Long-Term Registry
    Marco Canepa, Ewa Straburzyńska‐Migaj, Jarosław Dróżdż, Carla Fernández‐Vivancos, José Manuel García Pinilla, Noémi Nyolczas, Pier Luigi Temporelli, Alexandre Mebazaa, Mitja Lainščak, Cécile Laroche et al. · 2017 · European Journal of Heart Failure
  14. Liver Fibrosis Score Predicts Mortality in Heart Failure Patients with Preserved Ejection Fraction
    Akiomi Yoshihisa, Yu Sato, Tetsuro Yokokawa, Takamasa Sato, Satoshi Suzuki, Masayoshi Oikawa, Atsushi Kobayashi, Takayoshi Yamaki, Hiroyuki Kunii, Kazuhiko Nakazato et al. · 2017 · ESC Heart Failure
  15. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease
    Xiaochen He, Heng Zeng, Jian‐Xiong Chen · 2018 · Journal of Cellular Physiology
  16. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction
    Fan Dong, Abhijit R Takawale, Ratnadeep Basu, Vaibhav B. Patel, Jiwon Lee, Vijay Kandalam, Xiuhua Wang, Gavin Y. Oudit, Zamaneh Kassiri · 2014 · Cardiovascular Research
  17. Pathophysiology of heart failure and frailty: a common inflammatory origin?
    Lavanya Bellumkonda, Daniel J. Tyrrell, Scott L. Hummel, Daniel R. Goldstein · 2017 · Aging Cell
  18. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
    Jasper Tromp, Mohsin A.F. Khan, Robert John Mentz, Christopher M. O’Connor, Marco Metra, Howard C. Dittrich, Piotr P. Ponikowski, John R. Teerlink, Gad Cotter, Beth A. Davison et al. · 2017 · JACC Heart Failure
  19. Retinal microvascular dysfunction in heart failure
    Matthias P. Nägele, Jens Barthelmes, Valeria Ludovici, Silviya Cantatore, Arnold von Eckardstein, Frank Enseleit, Thomas Felix Lüscher, Frank Thomas Ruschitzka, Isabella Sudano, Andreas J. Flammer · 2017 · European Heart Journal
  20. Heart Failure Risk Associated With Rheumatoid Arthritis–Related Chronic Inflammation
    Michael J. Ahlers, Brandon D. Lowery, Eric H. Farber‐Eger, Thomas J. Wang, William S. Bradham, Michelle J. Ormseth, Cecilia P. Chung, Christoph Stein, Deepak K. Gupta · 2020 · Journal of the American Heart Association
  21. Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
    Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Elisabetta Moscarella, Felice Gragnano, Teresa Salvatore, Luca Rinaldi et al. · 2021 · International Journal of Molecular Sciences
  22. Epidemiology of Heart Failure
    Francesco Orso, Gianna Fabbri, Aldo Pietro Maggioni · 2016 · Handbook of experimental pharmacology
  23. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
    Alexander Peikert, Muthiah Vaduganathan, Brian Lee Claggett, Ian J. Kulac, Sheldon E. Litwin, Michael R. Zile, Akshay Suvas Desai, Pardeep S. Jhund, Jawad H. Butt, Carolyn S.P. Lam et al. · 2025 · European Heart Journal
  24. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction
    Mei Methawasin, Joshua G. Strom, Rebecca E. Slater, Vanessa Fernandez, Chandra Saripalli, Henk L. M. Granzier · 2016 · Circulation
  25. Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome
    Katherine W Lam, Kenneth W. Chow, Jonathan C. Vo, Wei Hou, Haifang Li, Paul S. Richman, Sandeep K. Mallipattu, Hal A. Skopicki, Adam J. Singer, Timothy Q. Duong · 2020 · The Journal of Infectious Diseases
  26. Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation
    Romain Gallet, Geoffrey de Couto, Eli Simsolo, Jackelyn Valle, Baiming Sun, Weixin Liu, Eleni Tseliou, Michael R. Zile, Eduardo Marbán · 2016 · JACC Basic to Translational Science
  27. Chronic low‐grade inflammation in heart failure with preserved ejection fraction
    Thássio Mesquita, Yen‐Nien Lin, Ahmed Gamal-Eldin Ibrahim · 2021 · Aging Cell
  28. Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
    Brendan Nicholas Putko, Zuocheng Wang, Jennifer Lo, Todd J. Anderson, Harald H. Becher, Jason R.B. Dyck, Zamaneh Kassiri, Gavin Y. Oudit, on behalf of the Alberta HEART Investigators · 2014 · PLoS ONE
  29. Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
    Barry A. Borlaug · 2013 · Circulation Journal
  30. Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes
    Milton Packer · 2021 · JACC Heart Failure
  31. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
    Micha Tobias Maeder, Otto Dagobert Schoch, Hans Rickli · 2016 · Vascular Health and Risk Management
  32. Preoperative systemic inflammation and perioperative myocardial injury: prospective observational multicentre cohort study of patients undergoing non-cardiac surgery
    Gareth L. Ackland, Tom E.F. Abbott, David J Cain, Mark Edwards, Pervez Sultan, Shamir N. Karmali, Alexander James Fowler, John Whittle, N.J. MacDonald, Anna Reyes et al. · 2018 · British Journal of Anaesthesia
  33. Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
    Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, Martin Johannes Hug, Jochen Seufert · 2022 · Molecular Metabolism
  34. The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
    Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, Ewa Pilichowska‐Paszkiet, Andrzej Budaj, Dariusz Sitkiewicz, Grażyna Sygitowicz · 2023 · International Journal of Molecular Sciences
  35. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure
    Stefanie Breitenstein, Lothar Roessig, Peter Sandner, Kelly S. Lewis · 2016 · Handbook of experimental pharmacology
  36. Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi‐Ethnic Study of Atherosclerosis)
    Daniel A. Duprez, Myron D. Gross, Jorge R. Kizer, Joachim H. Ix, William Gregory Hundley, David R. Jacobs · 2018 · Journal of the American Heart Association
  37. The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure
    Nicola Riccardo Pugliese, Stefano Masi, Stefano Taddei · 2019 · Heart Failure Reviews
  38. Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
    Keming Huang, Xianling Luo, Bin Liao, Guang Li, Jian Feng · 2023 · Cardiovascular Diabetology
  39. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
    Daniel Dalos, Julia Mascherbauer, Caroline Zotter‐Tufaro, Franz Duca, Andreas Anselm Kammerlander, Stefan Aschauer, Diana Bonderman · 2016 · Journal of the American College of Cardiology
  40. SIRT5‐Related Desuccinylation Modification Contributes to Quercetin‐Induced Protection against Heart Failure and High‐Glucose‐Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance
    Xing Chang, Tian Zhang, Junyan Wang, Yan Liu, Peizheng Yan, Qingyan Meng, Yongtian Yin, Shiyuan Wang · 2021 · Oxidative Medicine and Cellular Longevity · Retracted
  41. Influence of Epicardial and Visceral Fat on Left Ventricular Diastolic and Systolic Functions in Patients After Myocardial Infarction
    Ricardo Fontes‐Carvalho, Marta Fontes Oliveira, Francisco Sampaio, Jennifer Mâncio, Nuno Bettencourt, Madalena Teixeira, Francisco Rocha Gonçalves, Vasco Gama, Adelino Ferreira Leite-Moreira · 2014 · The American Journal of Cardiology
  42. Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men
    Peter Wohlfahrt, Margaret M. Redfield, Francisco Alejandro López-Jiménez, Vojtěch Melenovský, Garvan C. Kane, Richard J. Rodeheffer, Barry A. Borlaug · 2014 · JACC Heart Failure
  43. Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial
    Stavros Stavrakis, Khaled Elkholey, Lynsie M. Morris, Monika Niewiadomska, Zain Ul Abideen Asad, Mary Beth Humphrey · 2022 · Journal of the American Heart Association
  44. Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix
    Jagoda Kruszewska, Agnieszka Cudnoch‐Jędrzejewska, Katarzyna Czarzasta · 2022 · International Journal of Molecular Sciences
  45. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
    Roy, Clotilde, Slimani, Alisson, de Meester, Christophe, Amzulescu, Mihaela, Pasquet, Agnes, Vancraeynest, David, Beauloye, Christophe, Vanoverschelde, Jean-Louis, Gerber, Bernhard L., Pouleur, Anne-Catherine · 2018 · Journal of Cardiovascular Magnetic Resonance
  46. Association between Use of Statins and Mortality in Patients with Heart Failure and Ejection Fraction of ≥50%
    Alehagen, Urban, Benson, Lina, Edner, Magnus, Dahlström, Ulf, Lund, Lars H. · 2015 · Circulation Heart Failure
  47. Cardiac Disorders and Pathophysiology of Sarcomeric Proteins
    Jolanda van der Velden, Ger J.M. Stienen · 2018 · Physiological Reviews
  48. Inflammation in Metabolic Cardiomyopathy
    Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, Simon C Kraler, Thomas Felix Lüscher, Sarah Costantino, Francesco Paneni · 2021 · Frontiers in Cardiovascular Medicine
  49. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA
    Pasquale Paolisso, Alberto Foà, Luca Bergamaschi, Francesco Angeli, Michele Fabrizio, Francesco Donati, Sebastiano Toniolo, Chiara Chiti, Andrea Rinaldi, Andrea Stefanizzi et al. · 2021 · Cardiovascular Diabetology
  50. Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications
    Pankaj Garg, Rebecca C. Gosling, Peter Swoboda, Rachel S. Jones, Alexander M.K. Rothman, Jim M. Wild, David Gerard Kiely, Robin A Condliffe, Samer Alabed, Andrew J. Swift · 2022 · European Heart Journal
  51. Inflammation in Obesity-Related HFpEF
    Subodh Verma, Mark Colquhoun Petrie, Barry A. Borlaug, Javed Butler, Melanie Jane Davies, Dalane W. Kitzman, Sanjiv Jayendra Shah, Cecilia Rönnbäck, Steen Zabell Abildstrom, Karoline Liisberg et al. · 2024 · Journal of the American College of Cardiology
  52. Role of Biomarkers in Cardiac Structure Phenotyping in Heart Failure with Preserved Ejection Fraction: Critical Appraisal and Practical Use
    Emilia D’Elia, Muthiah Vaduganathan, Mauro Gori, Antonello Gavazzi, Javed Butler, Michele Senni · 2015 · European Journal of Heart Failure
  53. Mineralocorticoid Receptor Antagonism Treats Obesity-Associated Cardiac Diastolic Dysfunction
    Shawn B. Bender, Vincent Gerard DeMarco, Jaume Padilla, Nathan T. Jenkins, Javad Habibi, Mona Garro, Lakshmi Pulakat, Annayya Rao Aroor, Iris Zamir Jaffe, James R. Sowers · 2015 · Hypertension
  54. Heart failure with preserved ejection fraction: controversies, challenges and future directions
    Rosita Zakeri, Martín Cowie · 2018 · Heart
  55. Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction
    Matthew DeBerge, Sanjiv Jayendra Shah, Lisa D. Wilsbacher, Edward Benjamin Thorp · 2019 · Trends in Molecular Medicine
  56. Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis
    Diana Michels da Silva, Harald F. Langer, Tobias Graf · 2019 · International Journal of Molecular Sciences
  57. Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
    Jan Wintrich, Ingrid Kindermann, Christian Ukena, Simina‐Ramona Selejan, Christian M. Werner, Christoph Maack, Ulrich Laufs, Carsten Tschöpe, Stefan D. Anker, Carolyn S.P. Lam et al. · 2020 · Clinical Research in Cardiology
  58. Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction
    Parag Goyal, Zaid Almarzooq, Evelyn M. Horn, Maria G. Karas, Irina Sobol, Rajesh V. Swaminathan, Dmitriy N. Feldman, Robert M. Minutello, Harsimran Sachdeva Singh, Geoffrey W. Bergman et al. · 2016 · The American Journal of Medicine
  59. The actions of relaxin on the human cardiovascular system
    Mohsin Sarwar, Xiao‐Jun Du, Thomas Bernd Dschietzig, Roger J. Summers · 2016 · British Journal of Pharmacology
  60. An Integrative Translational Approach to Study Heart Failure with Preserved Ejection Fraction: A Position Paper from the Working Group on Myocardial Function of the European Society of Cardiology
    André Pedro Lourenço, Adelino Ferreira Leite-Moreira, Jean‐Luc Balligand, Johann K Bauersachs, Dana K. Dawson, Rudolf A. de Boer, León J. De Windt, Inês Falcão‐Pires, Ricardo Fontes‐Carvalho, Stefan Franz et al. · 2017 · European Journal of Heart Failure
  61. Soluble GC stimulators and activators: Past, present and future
    Peter Sandner, Markus Follmann, Eva Becker‐Pelster, Michael G. Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig, Johannes‐Peter Stasch · 2021 · British Journal of Pharmacology
  62. Signaling cascades in the failing heart and emerging therapeutic strategies
    Xin He, Tailai Du, Tianxin Long, Xinxue Liao, Yugang Dong, Zhan‐Peng Huang · 2022 · Signal Transduction and Targeted Therapy
  63. Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
    Pasquale Mone, Angela Lombardi, Urna Kansakar, Fahimeh Varzideh, Stanislovas S. Jankauskas, Antonella Pansini, Stefania Marzocco, Stefano De Gennaro, Michele Famiglietti, Gaetano Macina et al. · 2022 · Journal of Pharmacology and Experimental Therapeutics
  64. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves
    Dı́dac Mauricio, Mónica Gratacòs, Josep Franch‐Nadal · 2023 · Cardiovascular Diabetology
  65. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway
    Jibo Han, Chunpeng Zou, Liqin Mei, Yali Zhang, Yuanyuan Qian, Shengban You, Yong Pan, Zheng Xu, Bin Bai, Weijian Huang et al. · 2016 · Basic Research in Cardiology
  66. Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling
    Wynn G. Hunter, Jacob P. Kelly, Robert W. McGarrah, William E. Kraus, Svati Hasmukh Shah · 2016 · Current Heart Failure Reports
  67. Novel heart failure biomarkers: why do we fail to exploit their potential?
    Arnold Piek, Weijie Du, Rudolf A. de Boer, Herman H.W. Silljé · 2018 · Critical Reviews in Clinical Laboratory Sciences
  68. ROS signalling between endothelial cells and cardiac cells
    Min Zhang, Ajay M. Shah · 2014 · Cardiovascular Research
  69. Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation
    Thomas M. Gorter, Joost P. van Melle, Michiel Rienstra, Barry A. Borlaug, Yoran M. Hummel, Isabelle C. Van Gelder, Elke S. Hoendermis, Adriaan A. Voors, Dirk Jan van Veldhuisen, Carolyn S.P. Lam · 2017 · Journal of Cardiac Failure
  70. Neuroinflammation in heart failure: new insights for an old disease
    Hugo S. Díaz, Camilo Toledo, David Cristobal Andrade, Noah Justin Marcus, Rodrigo Del Río · 2019 · The Journal of Physiology
  71. Heart failure with preserved ejection fraction: Refocusing on diastole
    Antonio Abbate, Ross A Arena, Nayef Antar Abouzaki, Benjamin Wallace Van Tassell, Justin McNair Canada, Keyur B. Shah, Giuseppe Biondi‐Zoccai, Norbert Felix Voelkel · 2014 · International Journal of Cardiology
  72. Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
    Salvatore, Teresa, Galiero, Raffaele, Caturano, Alfredo, Vetrano, Erica, Loffredo, Giuseppe, Rinaldi, Luca, Catalini, Christian, Gjeloshi, Klodian, Albanese, Gaetana, Di Martino, Anna et al. · 2022 · Biomedicines
  73. Albuminuria Is Independently Associated With Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection Fraction
    Daniel H. Katz, Jacob A. Burns, Frank G. Aguilar, Lauren Beussink‐Nelson, Sanjiv Jayendra Shah · 2014 · JACC Heart Failure
  74. Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem.
    Bharathi Upadhya, Mark J. Haykowsky, Joel Eggebeen, Dalane W. Kitzman · 2015 · Europe PMC (PubMed Central)
  75. Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview
    Sanjiv Jayendra Shah · 2017 · Journal of Cardiovascular Translational Research
  76. The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection Fraction
    Aisha Gohar, Jenny P C Chong, Oi Wah Liew, Hester M. den Ruijter, Dominique P.V. de Kleijn, David Sim, Daniel Yeo, Hean Yee Ong, Fazlur Rehman Jaufeerally, Gerard Kui Toh Leong et al. · 2017 · European Journal of Heart Failure
  77. Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
    Michael S. Sabbah, Ahmed U. Fayyaz, Simon de Denus, Gary Michael Felker, Barry A. Borlaug, Surendra Dasari, Rickey E. Carter, Margaret M. Redfield · 2020 · Circulation Heart Failure
  78. SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes
    Xiaoqian Wu, Huan Liu, Alan C. Brooks, Suowen Xu, Jinque Luo, Rebbeca Steiner, Deanne M. Mickelsen, Christine Schomisch Moravec, Jeffrey D. Alexis, Eric M. Small et al. · 2022 · Circulation Research
  79. The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
    Farhad Bazgir, Julia Nau, Saeideh Nakhaei‐Rad, Ehsan Amin, Matthew J. Wolf, Jeffry J. Saucerman, Kristina Lorenz, Mohammad Reza Ahmadian · 2023 · Cells
  80. Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype
    Kosiborod, Mikhail N., Abildstrøm, Steen Z., Borlaug, Barry A., Butler, Javed, Christensen, Louise, Davies, Melanie, Hovingh, Kees G., Kitzman, Dalane W., Lindegaard, Marie L., Møller, Daniél Vega et al. · 2023 · JACC: Heart Failure
  81. Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity
    Brian Bostick, Javad Habibi, Lixin Ma, Annayya Rao Aroor, Nathan Rehmer, Melvin Ray Hayden, James R. Sowers · 2014 · Metabolism
  82. Understanding heart failure with preserved ejection fraction: where are we today?
    Loek van Heerebeek, Walter J. Paulus · 2016 · Netherlands Heart Journal
  83. Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    David Charles Hutchings, Simon George Anderson, Jessica L. Caldwell, Andrew W. Trafford · 2018 · Heart
  84. Heart Failure with Preserved Ejection Fraction: Diagnosis and Management
    Ohad Oren, Sheldon Goldberg · 2017 · The American Journal of Medicine
  85. Metabolic Effects of Metformin in the Failing Heart
    Aleksandra Dziubak, Grażyna Wójcicka, Andrzej Wojtak, Jerzy Bełtowski · 2018 · International Journal of Molecular Sciences
  86. Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
    Giuseppe Vergaro, Alberto Aimo, Concetta Prontera, Nicolò Ghionzoli, Chiara Arzilli, Luc Zyw, Claudia Taddei, Alessandra Gabutti, Roberta Poletti, Alberto Giannoni et al. · 2019 · International Journal of Cardiology
  87. The Future of Heart Failure Diagnosis, Therapy, and Management
    James E. Udelson, Lynne Warner Stevenson · 2016 · Circulation
  88. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction
    Rosita Zakeri, Gilles Moulay, Qiang Chai, Ozgur Ogut, Saad Hussain, Hiroyuki Takahama, Tong Lü, Xiao-Li Wang, Wolfgang Albrecht Linke, Hon-Chi Lee et al. · 2016 · Circulation Heart Failure
  89. The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac Events
    Ricardo Ladeiras‐Lopes, Francisco Sampaio, Nuno Bettencourt, Ricardo Fontes‐Carvalho, Nuno Dias Ferreira, Adelino Ferreira Leite-Moreira, Vasco Gama · 2016 · Revista Española de Cardiología (English Edition)
  90. Adiponectin resistance in skeletal muscle: Pathophysiological implications in chronic heart failure
    Sente, Tahnee, Van Berendoncks, An M, Hoymans, Vicky Y, Vrints, Christiaan J · 2016 · Journal of Cachexia, Sarcopenia and Muscle
  91. Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction
    Donato Cappetta, Grazia Esposito, Raffaele Coppini, Elena Piegari, Rosa Russo, Loreta Pia Ciuffreda, Alessia Rivellino, Lorenzo Santini, Concetta Rafaniello, Cristina Scavone et al. · 2017 · British Journal of Pharmacology
  92. Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
    Chao Ma, Huan Luo, Lei Fan, Xiaoyan Liu, Chengshan Gao · 2020 · Brazilian Journal of Medical and Biological Research
  93. Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction
    Robert John Mentz, David J. Whellan, Gordon R. Reeves, Amy M. Pastva, Pamela Woods Duncan, Bharathi Upadhya, Michael Benjamin Nelson, Haiying Chen, Shelby D. Reed, Paul B. Rosenberg et al. · 2021 · JACC Heart Failure
  94. Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
    Jens van de Wouw, Michelle Broekhuizen, Oana Sorop, Jaap A. Joles, Marianne Christina Verhaar, Dirk Jan Duncker, A.H. Jan Danser, Daphne Merkus · 2019 · Frontiers in Physiology
  95. Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals
    Masatake Kobayashi, Olivier Huttin, Martin Magnusson, João Pedro Ferreira, Erwan Bozec, Anne-Cécile Huby, Grégoire Preud’homme, Kévin Duarte, Zohra Lamiral, Kévin Dalleau et al. · 2021 · JACC. Cardiovascular imaging
  96. Psoriasis and Risk of Heart Failure: A Nationwide Cohort Study
    Usman Khalid, Ole Ahlehoff, Gunnar Gislason, Søren Lund Kristensen, Lone Skov, Christian Tobias Torp-Pedersen, Peter Riis Hansen · 2014 · European Journal of Heart Failure
  97. Prevention of the Development of Heart Failure with Preserved Ejection Fraction by the Phosphodiesterase-5A Inhibitor Vardenafil in Rats with Type 2 Diabetes
    Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, Marianna Török, Mihály Ruppert, Dalma Kellermayer, Bálint András Barta, Gabor B. Szabo, Gábor Kökény, Eszter Maria Horvath et al. · 2016 · European Journal of Heart Failure
  98. Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction
    Bharathi Upadhya, Barbara Pisani, Dalane W. Kitzman · 2017 · Journal of the American Geriatrics Society
  99. Altered mitochondrial metabolism in the insulin‐resistant heart
    Marina Makrecka‐Kuka, Edgars Liepinsh, Andrew J. Murray, Hélène Lemieux, Maija Dambrova, Kersti Tepp, Marju Puurand, Tuuli Käämbre, Woo Hyun Han, Paul de Goede et al. · 2019 · Acta Physiologica
  100. Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
    Alexander Е. Berezin, Alexander A. Berezin, Michael Lichtenauer · 2021 · Disease Markers